TenSixteen Bio Launches with Funding from Foresite Capital and GV As the First Company to Use CHIP to Treat Age-Related Diseases
SAN FRANCISCO--(BUSINESS WIRE)--TenSixteen Bio launched today with $40M from Foresite Capital and GV (formerly Google Ventures) on a mission to redefine precision medicine in complex disease by levera...